|
United States
Securities and Exchange Commission
Washington, D.C. 20549
|
||
|
SCHEDULE 13G
|
||
|
Under the Securities Exchange Act of 1934
|
||
|
(Amendment No. )*
|
||
| EMBECTA CORP. | ||
|
(Name of Issuer)
|
||
|
COMMON STOCK
|
||
|
(Title of Class of Securities)
|
||
|
29082K105
|
||
|
(CUSIP Number)
|
||
|
DECEMBER 31, 2022
|
||
|
(Date of Event Which Requires Filing of this Statement)
|
||
|
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
||
|
[ X ]
|
Rule 13d-1(b)
|
|
|
[ ]
|
Rule 13d-1(c)
|
|
|
[ ]
|
Rule 13d-1(d)
|
|
|
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
|
||
|
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
||
|
Page 1 of 9 Pages
|
||
|
CUSIP No. 29082K105
|
|||||
|
1.
|
Names of Reporting Persons
American Century Capital Portfolios, Inc.
|
||||
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
||||
|
(a)
|
[ ]
|
||||
|
(b)
|
[ ]
|
||||
|
3.
|
SEC Use Only
|
||||
|
4.
|
Citizenship or Place of Organization
Maryland
|
||||
|
5.
|
Sole Voting Power
|
3,850,818
|
|||
|
Number of Shares
Beneficially
|
6.
|
Shared Voting Power
|
N/A
|
||
|
Owned by
|
|||||
|
Each
Reporting
|
7.
|
Sole Dispositive Power
|
3,850,818
|
||
|
Person With:
|
|||||
|
8.
|
Shared Dispositive Power
|
N/A
|
|||
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
3,850,818
|
|||
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) [ ]
|
||||
|
11.
|
Percent of Class Represented by Amount in Row (9)
|
6.75%
|
|||
|
12.
|
Type of Reporting Person (See Instructions)
|
IV
|
|||
|
Page 2 of 9 pages
|
|||||
|
CUSIP No. 29082K105
|
|||||
|
1.
|
Names of Reporting Persons
American Century Investment Management, Inc.
|
||||
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
||||
|
(a)
|
[ ]
|
||||
|
(b)
|
[ ]
|
||||
|
3.
|
SEC Use Only
|
||||
|
4.
|
Citizenship or Place of Organization
Delaware
|
||||
|
5.
|
Sole Voting Power
|
5,395,700
|
|||
|
Number of Shares
Beneficially
|
6.
|
Shared Voting Power
|
N/A
|
||
|
Owned by
|
|||||
|
Each
Reporting
|
7.
|
Sole Dispositive Power
|
5,842,519
|
||
|
Person With:
|
|||||
|
8.
|
Shared Dispositive Power
|
N/A
|
|||
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
5,842,519
|
|||
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) [ ]
|
|
|||
|
11.
|
Percent of Class Represented by Amount in Row (9)
|
10.24%
|
|||
|
12.
|
Type of Reporting Person (See Instructions)
|
IA
|
|||
|
Page 3 of 9 pages
|
|||||
|
CUSIP No. 29082K105
|
|||||
|
1.
|
Names of Reporting Persons
American Century Companies, Inc.
|
||||
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
||||
|
(a)
|
[ ]
|
||||
|
(b)
|
[ ]
|
||||
|
3.
|
SEC Use Only
|
||||
|
4.
|
Citizenship or Place of Organization
Delaware
|
||||
|
5.
|
Sole Voting Power
|
5,395,700
|
|||
|
Number of Shares
Beneficially
|
6.
|
Shared Voting Power
|
N/A
|
||
|
Owned by
|
|||||
|
Each
Reporting
|
7.
|
Sole Dispositive Power
|
5,842,519
|
||
|
Person With:
|
|||||
|
8.
|
Shared Dispositive Power
|
N/A
|
|||
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
5,842,519
|
|||
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) [ ]
|
||||
|
11.
|
Percent of Class Represented by Amount in Row (9)
|
10.24%
|
|||
|
12.
|
Type of Reporting Person (See Instructions)
|
HC
|
|||
|
Page 4 of 9 pages
|
|||||
|
CUSIP No. 29082K105
|
|||||
|
1.
|
Names of Reporting Persons
Stowers Institute for Medical Research
|
||||
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
||||
|
(a)
|
[ ]
|
||||
|
(b)
|
[ ]
|
||||
|
3.
|
SEC Use Only
|
||||
|
4.
|
Citizenship or Place of Organization
Delaware
|
||||
|
5.
|
Sole Voting Power
|
5,395,700
|
|||
|
Number of Shares
Beneficially
|
6.
|
Shared Voting Power
|
N/A
|
||
|
Owned by
|
|||||
|
Each
Reporting
|
7.
|
Sole Dispositive Power
|
5,842,519
|
||
|
Person With:
|
|||||
|
8.
|
Shared Dispositive Power
|
N/A
|
|||
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
5,842,519
|
|||
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) [ ]
|
||||
|
11.
|
Percent of Class Represented by Amount in Row (9)
|
10.24%
|
|||
|
12.
|
Type of Reporting Person (See Instructions)
|
HC
|
|||
|
Page 5 of 9 pages
|
|||||
|
Item 1.
|
||
|
(a)
|
Name of Issuer.
|
|
|
Embecta Corp.
|
||
|
(b)
|
Address of Issuer’s Principal Executive Offices
|
|
|
300 Kimball Drive, Suite 300
Parsippany, New Jersey 07054
|
||
|
Item 2.
|
||
|
(a)
|
Name of Person Filing.
|
|
|
(1)
|
American Century Capital Portfolios, Inc.
|
|
|
(2)
|
American Century Investment Management, Inc.
|
|
|
(3)
|
American Century Companies, Inc.
|
|
| (4) | Stowers Institute for Medical Research | |
|
(b)
|
Address of Principal Business Office or, if none, Residence.
|
|
|
4500 Main Street
9th Floor
Kansas City, Missouri 64111
|
||
|
(c)
|
Citizenship.
|
|
|
(1)
|
Maryland
|
|
|
(2)
|
Delaware
|
|
|
(3)
|
Delaware
|
|
| (4) | Delaware | |
|
(d)
|
Title of Class of Securities.
|
|
|
Reference is made to the cover page of this filing.
|
||
|
(e)
|
CUSIP Number.
|
|
|
Reference is made to the cover page of this filing.
|
||
|
Page 6 of 9 pages
|
||
|
Item 3.
|
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
|
|
(1)
|
American Century Capital Portfolios, Inc. is an investment company registered under Section 8 of the Investment Company Act of 1940
(15 U.S.C. 80a-8).
|
|
|
(2)
|
American Century Investment Management, Inc. is an investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
|
|
|
(3)
|
American Century Companies, Inc. is a parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G). | |
| (4) | Stowers Institute for Medical Research, is a parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G). | |
|
Item 4.
|
Ownership.
|
|
|
Reference is made to Items 5-9 and 11 on the cover page of this filing.
|
||
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
|
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following [ ].
|
||
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
|
|
Various persons, including the investment companies and separate institutional investor accounts that American Century Investment
Management, Inc. (“ACIM”) serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule. Except as
may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM.
|
||
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent
Holding Company or Control Person.
|
|
|
See attached Exhibit A.
|
||
|
Item 8.
|
Identification and Classification of Members of the Group.
|
|
|
Not applicable.
|
||
|
Item 9.
|
Notice of Dissolution of Group.
|
|
|
Not applicable.
|
||
|
Page 7 of 9 pages
|
||
|
Item 10.
|
Certification
|
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held
in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as
a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is
true, complete and correct.
Dated this 9th day of January, 2023.
|
AMERICAN CENTURY CAPITAL PORTFOLIOS, INC. ("ACCP")
|
||
|
AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. (“ACIM”)
|
||
| AMERICAN CENTURY COMPANIES, INC. (“ACC”) | ||
|
By:
|
/s/ John Pak
|
|
|
John Pak
|
||
|
Senior Vice President, ACCP, ACIM and ACC
|
||
|
STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC
|
||
|
By:
|
/s/ Richard W. Brown
|
|
|
Richard W. Brown
|
||
|
Chairman
|
||
SCHEDULE 13G – To be included in statements filed pursuant to Rule 13d-1(b) or 13d-2(b).
EXHIBIT A
This Exhibit has been prepared to identify each subsidiary of American Century Companies, Inc. (“ACC”), which is controlled by the
Stowers Institute for Medical Research, that is a beneficial owner of securities that are the subject of this schedule (the “Subject Securities”). American Century Investment Management, Inc. (“ACIM”) is a wholly-owned subsidiary of ACC and an
investment adviser registered under §203 of the Investment Advisers Act of 1940.
Page 8 of 9 pages
SCHEDULE 13G – To be included in statements filed pursuant to Rule 13d-1(b) or 13d-2(b) and Rule 13d-1(f) (1)
Agreement.
EXHIBIT B
Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment
Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule.
Dated this 9th day of January, 2023.
|
AMERICAN CENTURY CAPITAL PORTFOLIOS, INC. ("ACCP")
|
||
|
AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. (“ACIM”)
|
||
| AMERICAN CENTURY COMPANIES, INC. (“ACC”) | ||
|
By:
|
/s/ John Pak
|
|
|
John Pak
|
||
|
Senior Vice President, ACCP, ACIM and ACC
|
||
|
STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC
|
||
|
By:
|
/s/ Richard W. Brown
|
|
|
Richard W. Brown
|
||
|
Chairman
|
||
Page 9 of 9 pages
Forward Looking Statement
The information included on this website and other information provided from time to time through webcasts, conference calls, securities analyst meetings, road show presentations, investor conferences, transcripts, newsletters and similar events and communications contains “forward-looking statements”, as that term is defined in the Private Securities Litigation Reform Act of 1995 and other securities laws, based on current expectations and assumptions that involve risks and uncertainties. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of embecta may differ materially from those expressed or implied by such forward-looking statements and assumptions.These statements use words such as "will," "plan," "expect," "anticipate," "estimate," "next," "project," "potential," "continue," "expand" and "grow" and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance and statements regarding our business strategy, impact of mergers and acquisitions,future product development, regulatory clearances and approvals, competitive position and expenditures.These statements are based on current assumptions and expectations of future events at the time they are made and thus are inherently subject to uncertainty.
All such statements are based upon current expectations of embecta and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Many of these risks and uncertainties are beyond the company's control. For a discussion of certain factors that could cause our actual results to differ from our expectations in any forward-looking statements see our latest Annual Report on Form 10-K and other filings with the SEC. embecta expressly disclaims any undertaking to update or revise any forward looking statements set forth herein to reflect events or circumstances after the date hereof, except as required by applicable law or regulation.